Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

55.15 +1.38 (+2.57%)
Official Closing Price Updated: 4:15 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
34 35 Next >
News headline image
2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗
Both companies have game-changing product portfolios that should result in stock price growth. 
Via The Motley Fool
News headline image
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy? ↗
Vertex shares are on the rise. 
Via The Motley Fool
News headline image
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
The 10 Best Stocks to Buy in April 2023 ↗
Here are 10 stocks to buy now that could unlock explosive gains in your growth-stock portfolio. 
Via The Motley Fool
News headline image
Why Bluebird Bio Shares Are Plunging Today ↗
 
Via Benzinga
News headline image
Could This Stock Become the Tesla of Its Industry? ↗
It's in a race to a multi-billion dollar market. 
Via The Motley Fool
News headline image
Expert Ratings for CRISPR Therapeutics ↗
 
Via Benzinga
News headline image
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics ↗
Together, the companies could produce a game-changing product. 
Via The Motley Fool
News headline image
5 Bargain-Basement Stocks to Buy Right Now ↗
Down markets offer us something very positive: deals on quality companies. 
Via The Motley Fool
News headline image
The 3 Best Growth Stocks to Buy in the Biotech Sector ↗
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors. 
Via InvestorPlace
News headline image
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures ↗
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine. 
Via InvestorPlace
News headline image
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Could CRISPR Therapeutics Become the Next Moderna? ↗
Both companies use cutting-edge technology. 
Via The Motley Fool
News headline image
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it. 
Via InvestorPlace
News headline image
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence ↗
Your stock screening and research process will never be the same. 
Via The Motley Fool
News headline image
This Cathie Wood Stock Could Nearly Double, According to Wall Street ↗
If the stock market continues to rally, this biotech could benefit. 
Via The Motley Fool
News headline image
Thinking of Buying Biotech Stocks? Do These 3 Things First ↗
It's better to plan ahead than to get caught by surprise. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗
 
Via Benzinga
News headline image
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time ↗
For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow. 
Via InvestorPlace
News headline image
3 Beaten-Down Stocks That Could Soar This Year ↗
These stocks could enjoy big rebounds in 2023. 
Via The Motley Fool
News headline image
2 Top Biotech Stocks to Buy for the Long Haul ↗
These companies have what it takes to grow their revenues -- and their share prices -- over time. 
Via The Motley Fool
News headline image
If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today ↗
The stock has been on a wild ride over the past few years. 
Via The Motley Fool
News headline image
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold ↗
Get in on CRISPR Therapeutics before it gets expensive. 
Via The Motley Fool
News headline image
2 Healthcare Stocks That Could Help Make You a Fortune ↗
These companies also happen to be a bargain right now. 
Via The Motley Fool
News headline image
7 Cathie Wood Stocks for Your March Buy List ↗
These top Cathie Wood stocks are just now attempting to pivot higher after a miserable outing for much of 2022. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗
 
Via Benzinga
News headline image
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing ↗
CRISPR Therapeutics, Beam Therapeutics and Vertex Pharmaceuticals are three CRISPR gene editing stocks you won't want to miss out on. 
Via InvestorPlace
News headline image
Better Growth Stock: Moderna vs. CRISPR Therapeutics ↗
Both stocks are ripe for a rebound. 
Via The Motley Fool
News headline image
3 Things About CRISPR Therapeutics That Smart Investors Know ↗
Institutional investors might be on to something. 
Via The Motley Fool
News headline image
3 Game-Changing Stocks to Buy in March ↗
Innovation is in these companies' DNA. 
Via The Motley Fool
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.